Summary of opinion: Padcev, 21/05/2026 Positive

Human medicines European public assessment report (EPAR): Vijoice, alpelisib, Status: Opinion

Summary of opinion: Keytruda, 21/05/2026 Positive

Hantavirus

PSUSA/00003006/202503

Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of authorisation: 22/07/2014, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid, Date of authorisation: 16/08/2012, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 23, Status: Authorised

Scientific advice and protocol assistance adopted during the CHMP meeting 20-23 April 2026

Human medicines European public assessment report (EPAR): Exjade, deferasirox, Date of authorisation: 28/08/2006, Revision: 58, Status: Authorised